Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05034380 · ClinicalTrials.gov registry record · NA

Epigenetic Effects of a Single Bout of Exercise on Cardiovascular Risk Factors and the Metabolome

A NA study, sponsored by East Carolina University.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT05034380: Completed NA study, sponsored by East Carolina University.

NCT05034380 is a NA study that has completed, run by East Carolina University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05034380, a NA study, has completed, sponsored by East Carolina University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this study is to determine the ability of acute exercise to regulate fat metabolism in muscle of overweight and obese people compared to lean people.

Primary Outcome

Metabolomics of skeletal muscle acylcarnitines is used as a measure of mitochondrial function by assessing long, medium and short chain acylcarnitine levels.

Interventions

  • BEHAVIORAL Acute exercise

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2014-09-14
Est. Completion 2016-03-14
Phase NA
East Carolina University

58 total trials

What the finished NCT05034380 record still lists

NCT05034380 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Acute exercise is the first listed.

NCT05034380 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05034380 about?

NCT05034380 is a clinical study titled "Epigenetic Effects of a Single Bout of Exercise on Cardiovascular Risk Factors and the Metabolome". The purpose of this study is to determine the ability of acute exercise to regulate fat metabolism in muscle of overweight and obese people compared to lean people.

What is the current status of trial NCT05034380?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-09-14. Estimated completion is 2016-03-14.

What interventions are being tested in trial NCT05034380?

The interventions under investigation include: Acute exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05034380?

This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05034380's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05034380, the US trial registry maintained by the National Library of Medicine. NCT05034380 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.